Allergan, Valeant Pharmaceuticals deal

On Aug. 26, Allergan set a Dec. 18 date for a special shareholder meeting at which Valeant and Allergan’s largest shareholder, hedge fund Pershing Square Capital, hope to install board members who

Read the full 329 word article

How to gain access

Continue reading with a
two-week free trial.